
Masimo (MASI) Stock Forecast & Price Target
Masimo (MASI) Analyst Ratings
Bulls say
Masimo Corp demonstrated strong operational performance with driver shipments reaching 65,000, exceeding expectations, and displaying an 8% quarter-over-quarter and 11% year-over-year increase. Both gross and operating margins showed significant improvement, with gross margin rising by 240 basis points and operating margin expanding by 570 basis points year-over-year, reinforcing the company’s financial health. Additionally, management has reaffirmed their revenue growth guidance for 2025 at 8-11%, while also raising earnings per share guidance, indicating confidence in sustained financial performance and potential for further market share gains across its healthcare and non-healthcare segments.
Bears say
Masimo Corp experienced a slowdown in revenue growth, with a 9% increase in 4Q24 compared to a 12% growth in 3Q24, reflecting declining performance in its critical healthcare segment. The company's bear case scenario suggests that revenue could further decelerate to mid-single digits due to decreased market share and disappointing new product sales, leading to weaker operating margins and earnings below consensus expectations. Additionally, risks such as supply chain disruptions, underwhelming sales from its non-healthcare segment, and adverse impacts from emerging health trends threaten to exacerbate the downturn in Masimo’s financial health.
This aggregate rating is based on analysts' research of Masimo and is not a guaranteed prediction by Public.com or investment advice.
Masimo (MASI) Analyst Forecast & Price Prediction
Start investing in Masimo (MASI)
Order type
Buy in
Order amount
Est. shares
0 shares